Clinical Trials Logo

Insomnia clinical trials

View clinical trials related to Insomnia.

Filter by:

NCT ID: NCT03492905 Completed - Insomnia Clinical Trials

Implementation of Internet-based Cognitive Behaviour Therapy for Adolescents With Co-morbid Insomnia

Start date: March 12, 2018
Phase: N/A
Study type: Interventional

Insomnia is a commonly reported comorbidity for adolescents with psychiatric conditions. It is well-known that insomnia can exacerbate the concurrent psychiatric symptom load. Results from a pilot study shows that outpatients of Children and Youth Psychiatry can improve their sleep and depressive symptoms by receiving internet-based cognitive behavioral therapy for insomnia (iCBT). This study is designed to evaluate implementation of the treatment in routine care.The study will evaluate aspects of the implementation process such as organizational attitudes towards iCBT before implementation, level of knowledge about the condition and intervention among health-care providers before and after the implementation, and clinical outcomes in routine care.

NCT ID: NCT03468400 Completed - Insomnia Clinical Trials

Evaluation of the Reliability and Validity of a Diagnostic Sleep Disorders Questionnaire

Start date: March 1, 2018
Phase:
Study type: Observational

The study aims to develop and test a user-friendly, accessible approach to sleep assessment which can function as an initial "triage" of targeted sleep conditions, such as insomnia, insufficient sleep syndrome, sleep apnea syndromes/snoring, and circadian sleep/wake disorders, within the clinical and community population. Specifically, this study will test the validity and reliability of a self-rated, digitized, and cost-effective diagnostic measure with sufficient sensitivity to accurately assess/diagnose common sleep conditions and/or risk for these conditions. Such an approach, would allow for faster assessment of common sleep conditions and disorders, and provide clinical knowledge to the individual, the physician, and if required insurance companies, as to those persons who need more immediate attention or treatment for their sleep condition.

NCT ID: NCT03447665 Completed - Insomnia Clinical Trials

Infant Behavioral Sleep Intervention: Comparative Efficacy

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

While frequent night awakenings in newborns are common and expected, an estimated 20-30% of older infants and toddlers have frequent problematic night wakings requiring parental intervention throughout the night. Standard infant behavioral sleep intervention approaches, which require parental intervention throughout the night, are effective but often difficult for families to implement. The aim of this study is to compare the efficacy of two infant behavioral sleep interventions with a no treatment condition, on infant sleep and family functioning. Healthy infants between the ages of 6 and 18 months with night wakings will be randomized into one of three conditions: Entire night intervention, bedtime only intervention, or no treatment.

NCT ID: NCT03445299 Completed - Dementia Clinical Trials

Music for Dementia-related Sleep Problems

Start date: February 26, 2018
Phase: N/A
Study type: Interventional

The study aims to evaluate the effect of listening to music at bedtime on sleep in elderly persons with dementia and sleep problems.

NCT ID: NCT03444532 Completed - Insomnia Clinical Trials

Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia

Start date: March 2, 2018
Phase: N/A
Study type: Interventional

This study of a randomized controlled trial aims to evaluate the feasibility of a 12-week sleep program and the randomized controlled trial research procedure. In total 20 participants will be recruited and randomized to the intervention or control group.

NCT ID: NCT03438331 Completed - Depression Clinical Trials

Effects of Group Cognitive Behavioural Therapy on Comorbid Insomnia and Depression in Youth

Start date: May 15, 2018
Phase: N/A
Study type: Interventional

Major depressive disorder (MDD) is among the most common psychiatric disorders among adolescents, and is associated with considerable psychosocial and functional impairments and an elevated risk of suicidal behaviour and completed suicide. Meanwhile, sleep disturbance, particularly insomnia, is among the most prevalent and prominent presenting complaints in adolescents with depression. Despite its high prevalence, insomnia often remains overlooked and under-treated in clinical practice. However, growing evidence suggests an intricate relationship between insomnia and depression, which has become an area in need of further focused attention. This project will involve a randomised controlled trial proposed to examine whether insomnia treatment confers additional benefit to depression treatment in adolescents with comorbid depression and insomnia, for improving sleep and depressive symptoms, and other clinical and daytime symptoms as well as overall functional improvement in both the short and long term. Eligible adolescent participants will be randomised to either intervention (8-week group Cognitive Behavioural Therapy for Insomnia, CBT-I, or 8-week group Cognitive Behavioural Therapy for Depression, CBT-D) or waiting-list control condition. Assessments will be conducted at pre-treatment (week 0), during the treatment (week 2, 4, 6) and post-treatment (week 8/at the conclusion of the last group session). The two active treatment groups will be additionally followed up at posttreatment one-month and six-month.

NCT ID: NCT03432091 Completed - Insomnia Clinical Trials

Melatonin Receptor Agonist and Peripheral Biological Markers

Start date: January 11, 2016
Phase:
Study type: Observational

People who have insomnia typically co-occur with mental disorders, especially anxiety and depression. It has been documented that the melatonin phase in the depressed patients was reached with a delay. Melatonin plays a crucial role in regulation of circadian-clock-related gene expression.

NCT ID: NCT03397472 Completed - Insomnia Clinical Trials

Magnetic Field Modulation Pillow for Insomnia Clinical Trial

Start date: January 18, 2018
Phase: N/A
Study type: Interventional

This interventional study was designed to explore the clinical effect of magnetic field modulation system on insomnia patients and provide a new solution for insomnia treatment.

NCT ID: NCT03390114 Completed - Insomnia Clinical Trials

Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

The goal of this preliminary study is to determine the efficacy of an internet-based treatment program for insomnia for HIV-infected persons.

NCT ID: NCT03366870 Completed - Insomnia Clinical Trials

Efficacy of a Computerized Cognitive Behavioral Treatment for Insomnia: Increasing Access to Insomnia Treatment to Decrease Suicide Risk

Vets Sleep
Start date: March 24, 2018
Phase: N/A
Study type: Interventional

Insomnia is major problem among Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) Veterans. Insomnia impacts physical and mental health functioning and is associated with reduced quality of life. Cognitive Behavioral Therapy for Insomnia (CBT-I) is one of the most promising treatments for insomnia; however, access to CBT-I is severely limited by a lack of trained clinicians within the Veterans Health Administration (VHA) and Department of Defense (DoD). There is a critical need to offer innovative approaches to meet the demand and need for insomnia treatment. Leveraging technology to meet treatment demands is consistent with service delivery models based upon stepped care principles. This randomized controlled trial will determine whether a computerized, self-guided, web-based version of CBT-I is efficacious in reducing insomnia symptoms and improving functioning compared to a computerized program control.